| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized, single-blinded cross-over trial of ischemic preconditioning in Raynaud's phenomenon
|
Neferu, Ramona
|
|
2017
|
2 |
3 |
p. 213-220
|
artikel
|
| 2 |
Combined PRP and microfat graft for facial disability in systemic sclerosis
|
Philandrianos, Cécile
|
|
2017
|
2 |
3 |
p. e7-e11
|
artikel
|
| 3 |
Differential expression of hepatocyte growth factor in patients with systemic sclerosis-associated pulmonary arterial hypertension
|
Sung, Yon K.
|
|
2017
|
2 |
3 |
p. 225-230
|
artikel
|
| 4 |
Functional autoantibodies directed against cell surface receptors in systemic sclerosis
|
Cabral-Marques, Otavio
|
|
2017
|
2 |
3 |
p. 160-168
|
artikel
|
| 5 |
High sensitivity troponin might be a marker of subclinical scleroderma heart involvement: a preliminary study
|
Barsotti, Simone
|
|
2017
|
2 |
3 |
p. 183-187
|
artikel
|
| 6 |
Mechanistic and clinical insights at the scleroderma-cancer interface
|
Shah, Ami A.
|
|
2017
|
2 |
3 |
p. 153-159
|
artikel
|
| 7 |
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
|
Varga, John
|
|
2017
|
2 |
3 |
p. 137-152
|
artikel
|
| 8 |
Paul Klee's illness – a series of historical and clinical vignettes
|
Silver, Richard M.
|
|
2017
|
2 |
3 |
p. 135-136
|
artikel
|
| 9 |
Prevalence and incidence of pulmonary arterial hypertension: 10-year follow-up of an unselected systemic sclerosis cohort
|
Vandecasteele, Els
|
|
2017
|
2 |
3 |
p. 196-202
|
artikel
|
| 10 |
Pulmonary arterial hypertension screening of systemic sclerosis patients in clinical practice: an independent chart review
|
Kelly, Dylan
|
|
2017
|
2 |
3 |
p. 231-234
|
artikel
|
| 11 |
Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients
|
Foeldvari, Ivan
|
|
2017
|
2 |
3 |
p. 203-207
|
artikel
|
| 12 |
Ulnar artery vasculopathy: a common but nonspecific feature of systemic sclerosis
|
Kim, Tae-Jong
|
|
2017
|
2 |
3 |
p. 221-224
|
artikel
|
| 13 |
Use of intravenous epoprostenol as a treatment for the digital vasculopathy associated with the scleroderma spectrum of diseases
|
Law, Shing T.
|
|
2017
|
2 |
3 |
p. 208-212
|
artikel
|
| 14 |
Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis
|
Morrisroe, Kathleen
|
|
2017
|
2 |
3 |
p. 188-195
|
artikel
|
| 15 |
What have multicentre registries across the world taught us about the disease features of systemic sclerosis?
|
Proudman, Susanna M.
|
|
2017
|
2 |
3 |
p. 169-182
|
artikel
|
Tijdschrift beschrijving